KOHEN AVOCATS · PARIS, FRANCE
Report fraud: how to report Medicare billing fraud and what happens after you file

Hassan Kohen is a Paris-based lawyer admitted to the Paris Bar (Avocat au Barreau de Paris). Initial strategic analysis: €80 incl. VAT, personal reply within 24 hours.

100% confidential · Legal professional privilege · No obligation

Article generated by artificial intelligence, through a process designed and supervised by the firm

Sources: U.S. court opinions and official U.S. government publications, read for this article

Maître Hassan KOHEN, avocat au Barreau de Paris
Hassan KOHEN
Attorney at the Paris Bar

Report fraud: how to report Medicare billing fraud and what happens after you file

Speak to a lawyer 06 89 11 34 45

U.S. searches for fraud jumped on November 17 and 18, 2026, and related queries show readers want to know how to report it. The practical question behind that spike: how do you report suspected Medicare billing fraud, and what happens after you file?

The short answer is that the crackdown is real but specific. In the last two years, federal prosecutors brought the largest health care fraud takedown in Justice Department history, the Centers for Medicare and Medicaid Services blocked billions of dollars in suspect payments, and CMS opened a public request for information on a possible new anti-fraud rule known as CRUSH. None of that means every bill is suspect. It does mean three things worth understanding: what the enforcement surge actually consists of, how a routine bill can get flagged, and what federal judges did in three recent cases that look like the patterns now in the news.

This article walks through each point in order. The first part describes the enforcement surge and the review tools behind it. The second part applies three federal appellate decisions from 2026, two criminal and one civil, to the checks a reader can run on their own statements. Every legal rule below is federal, every case was decided by a named federal court of appeals in 2026, and every proposition links to the official source read for this article.

I. What the federal fraud crackdown is and what it can touch

A. The enforcement surge readers are reacting to

The centerpiece of the current enforcement wave is the 2025 National Health Care Fraud Takedown, whose results the Justice Department published as the largest health care fraud takedown in Justice Department history. According to the Department’s release dated 2025, prosecutors charged 324 defendants, including 96 doctors, nurse practitioners, pharmacists, and other licensed medical professionals, across 50 federal districts and 12 State Attorneys General’s Offices, for schemes involving more than $14.6 billion in intended loss. The release states that agents seized more than $245 million in cash, luxury vehicles, cryptocurrency, and other assets, and that the Centers for Medicare and Medicaid Services stopped more than $4 billion from being paid on false and fraudulent claims while suspending or revoking the billing privileges of 205 providers in the months before the takedown. Civil charges against 20 defendants for $14.2 million in alleged fraud, and civil settlements with 106 defendants totaling $34.3 million, were announced as part of the same effort.

A separate track continued into 2026. The Justice Department’s 2026 National Health Care Fraud Takedown describes charges tied to schemes involving more than $4 billion in fraudulent claims for durable medical equipment, skin substitutes, and wound care products. Durable equipment, genetic testing, and wound care products recur across these announcements: they are high-dollar, often ordered remotely, and easy to bill without ever seeing the patient, which is why they draw enforcement attention.

The newest piece, and the one driving this week’s coverage, is a proposal rather than a finished rule. On February 27, 2026, the Centers for Medicare and Medicaid Services published a CRUSH request for information (Comprehensive Regulations To Uncover Suspicious Healthcare), file code CMS-6098-NC, with comments due by March 30, 2026. The notice states that it solicits stakeholder feedback on potential regulatory changes for a possible upcoming CRUSH proposed rule, as well as other programmatic changes, in order to make CMS more effective in crushing fraud to protect taxpayer dollars and the Americans we serve. That distinction matters for readers: a request for information imposes no new billing duty by itself. It signals where CMS may write rules next, including enrollment controls, payment suspensions, and billing-privilege revocations of the kind the 2025 takedown already used. If a headline says a crackdown is “proposed,” check whether it cites an RFI, a proposed rule, or a final rule, because only the last one changes what the law requires today.

CMS also publishes a standing booklet for providers, Medicare Fraud and Abuse: Prevent, Detect, Report, which lists the federal laws in play: the Federal False Claims Act, the Anti-Kickback Statute, the physician self-referral law known as the Stark Law, the criminal health care fraud statute, the exclusion statute, and the civil monetary penalties law. The booklet’s catalog of the governing laws is a useful map: criminal prosecution, civil false-claims suits, kickback liability, exclusion from federal programs, and civil money penalties are separate tools, and a single billing pattern can trigger more than one of them. A patient does not need to master each statute. The practical point is narrower: when a bill looks wrong, more than one enforcement door may be open, and the reader’s job is to document the facts accurately and use the right channel.

B. How an ordinary medical bill can get pulled into review

Most bills flagged in a fraud crackdown are not flagged because the patient did something wrong. They are flagged because something about the claim looks medically unnecessary, undocumented, or inconsistent with the visit that supposedly produced it. Common patterns in recent enforcement include bills for genetic tests the patient never discussed with a clinician, equipment that never arrived, telemedicine visits that never happened, and routine services billed under codes that imply a more complex encounter than the one documented. CMS’s provider booklet organizes its prevention advice around accurate coding and billing, documentation, and upcoding for evaluation and management services, which tells readers where reviewers look first: the match between what the record says happened and what the claim says was furnished.

For a reader holding a confusing bill or Medicare Summary Notice, the first check costs nothing and mirrors what Medicare itself recommends. Medicare’s official reporting page tells beneficiaries to compare the dates and services on your calendar with the Medicare statements you get to confirm that each listed service was actually received and that the details are correct. Concretely, that means lining up each date of service on the statement with appointments, facility visits, telehealth calls, delivered equipment, and lab draws the reader can verify from a personal calendar, a patient portal, or a pharmacy record. A genetic test, a back brace, a wound-care supply, or a telemedicine visit that appears with no matching memory, message, or shipment is the single most useful fact to isolate, because every enforcement pattern in this article turns on services billed but never furnished or never ordered by a treating clinician who examined the patient.

The second check is to separate mistake from fraud without accusing anyone. Coding errors, duplicate claims, wrong dates of service, and mix-ups between family members on the same account happen regularly, and many are fixed with a call to the provider’s billing office and, if needed, a corrected claim. Fraud, in the criminal sense pursued under 18 U.S.C. 1347, requires a knowing and willful scheme, which is why the criminal cases below focus on people who signed, ordered, or billed for things they knew the patient never got. A reader should therefore write down, before calling anyone, exactly what is disputed: the date, the service description, the amount, why personal records contradict it, and what documents support that view. That note protects the reader twice. If the problem is a clerical error, the note speeds the correction. If the problem is real, the note becomes the basis of a report through Medicare’s official fraud reporting channel, which is the route Medicare itself provides for suspected fraud and abuse, and it preserves details that fade quickly, such as who ordered a test and whether any clinician discussed it.

The third check is to understand what the government can do to providers, because that explains the leverage behind a correction. Beyond criminal prosecution, federal law provides civil remedies for false Medicare claims, exclusion of providers from federal health care programs, and civil money penalties, and CMS used payment blocks and billing-privilege revocations at scale in the 2025 takedown. The civil monetary penalties law, 42 U.S.C. 1320a-7a, is one of the authorities behind that civil enforcement, and its official text sets out the penalty framework that applies alongside program exclusion. A reader never imposes these sanctions personally; their relevance is indirect but practical. A provider that receives a documented, specific, written dispute knows the billing office is not the only audience that could eventually read the file, and documented disputes are resolved faster than vague complaints precisely because the paper trail is clear.

One caution applies to every step. Do not sign blank forms, do not give a Medicare number to a caller or a door-to-door marketer offering “free” genetic tests or equipment, and do not agree by phone to equipment or testing no treating clinician has discussed. The criminal cases below show why: once a signature or an authorization exists, the biller can present the claim as patient-approved, and undoing that paper takes far longer than refusing it in the first place. If a test or device is genuinely wanted, the safe path is an order from the reader’s own treating clinician, documented in the visit note, with delivery confirmed before any bill is paid.

II. What federal judges actually did in three comparable cases

A. Criminal cases: bills for care the patient never received

The most useful criminal precedent for this week’s question comes from the United States Court of Appeals for the Fourth Circuit. In United States v. Joyner, No. 24-4565 (4th Cir. Aug. 12, 2026), the court reviewed the conviction of Colby Joyner, a licensed physician assistant who took a part-time remote job with a telehealth company. His task was to review patient files and sign forms ordering genetic tests for Medicare beneficiaries. Over ten months, Joyner signed orders for some 607 beneficiaries he certified as his patients, although he had spoken with only about 20 of them. For each file he reviewed, he was paid $12 to $15, whether or not he approved the testing. Based on his orders, laboratories billed Medicare for more than 14,600 tests, seeking over $10 million. A jury convicted Joyner of health care fraud under 18 U.S.C. 1347 and of making false statements in connection with health care matters, and the district court imposed 72 months in prison. The Fourth Circuit rejected his challenges to evidentiary rulings, trial subpoenas, and sentencing, holding that the rulings lay within the district court’s discretion and the findings were not clearly erroneous, and it closed with the short holding that the judgment of the district court is AFFIRMED.

The application for readers is direct. Joyner’s case is the template for the genetic-testing bills now drawing enforcement attention: a remote signer, beneficiaries who never became real patients, per-file payments regardless of medical judgment, and laboratories billing Medicare at scale. Anyone who receives a statement showing genetic tests never discussed with any clinician is looking at the same pattern the Fourth Circuit just affirmed as a federal crime. The concrete checks follow from the opinion’s facts: confirm whether any clinician examined the reader or took a history before the test date, look for a visit note or portal message supporting the order, and treat a bill for testing ordered by an unfamiliar remote company as the fact to document and report, not as a routine balance to pay without questions. Joyner’s defense, that he was a small player who trusted the company’s compliance process, failed because the jury was entitled to reject it on the sheer volume of orders for strangers. Readers should draw the parallel carefully and in the right direction: the opinion punishes the signer and the billing chain, not the beneficiary, and a beneficiary who documents and reports an unfamiliar order is behaving exactly as the enforcement system expects.

The United States Court of Appeals for the Ninth Circuit addressed the equipment side of the same pattern in February 2026. In United States v. Motley, No. 23-3971 (9th Cir. Feb. 24, 2026), the court reviewed the case of Tamara Motley, whom a jury convicted of defrauding Medicare by submitting millions of dollars in false and fraudulent claims for durable medical equipment and related services. The opinion explains that enrolled in Medicare under her relatives’ names rather than her own. Her underlying health care fraud was not disputed on appeal; the only question was whether she also committed aggravated identity theft, and the court held that count could not stand under the Supreme Court’s intervening Dubin decision, vacating that portion of her sentence and remanding for resentencing while leaving the fraud itself established. Readers can verify that result in the published opinion, which states the fraud and explains the limit in the same pages.

Motley widens the lesson of Joyner from genetic testing to the equipment bills now under scrutiny: devices and related services billed at scale for patients who received little or nothing. The reader’s application is a three-line audit of any complex statement. First, equipment: did the item arrive, was it fitted or delivered as described, and does the delivery date match the service date? Second, testing: is there a clinician, a conversation, and a note tying the test to a symptom or condition? Third, suppliers: is the billing company one the reader recognizes from their own care, rather than an unfamiliar name? A “no” on any line does not prove fraud by itself, but the Motley pattern shows that prosecutors build cases exactly from stacks of such “no” answers across many beneficiaries. Civil exposure runs on a separate track: the False Claims Act reaches knowing false claims for federal money, which is why equipment and testing billed without ever seeing the patient draws both criminal and civil attention. One patient’s documented “no,” reported through the proper channel, is how those stacks start. Conversely, statements that match the reader’s records, even during a crackdown, call for no action beyond keeping the records, because enforcement targets billing disconnected from care, not care itself.

B. Civil cases: who can challenge a false Medicare bill, and the price of vague allegations

Not every false bill becomes a criminal case. Many are pursued civilly under the False Claims Act, which lets the government recover for knowing false claims for federal money and lets private relators sue in the government’s name and share in the recovery. A decision of the United States Court of Appeals for the Seventh Circuit from August 2026 shows both the power and the discipline of that route. In Enloe v. Heritage Operations Group, LLC, No. 24-1431 (7th Cir. Aug. 17, 2026), relator A. Samuel Enloe, suing on behalf of the United States and the State of Illinois, alleged that Heritage Operations Group, which runs about forty long-term care facilities in Illinois, and Green Tree Pharmacy dispensed controlled substances to residents without valid prescriptions and without pharmacist approval, in violation of the Controlled Substances Act, and then submitted fraudulent claims to Medicare in violation of the False Claims Act. The district court dismissed the second amended complaint at the pleading stage, finding that Enloe failed to plead fraud with the particularity that Federal Rule of Civil Procedure 9(b) demands. The Seventh Circuit agreed with that analysis throughout and closed its opinion with the holding that accordingly, we AFFIRM the judgment of the district court.

The application cuts in two directions, and both matter for readers. For potential whistleblowers, including facility staff and pharmacy workers who see systematic billing abuse, Enloe is a warning about preparation: a civil false-claims complaint must identify the who, what, when, and how of the alleged fraud with specific facts, and courts dismiss complaints that assume unlawful practices from vague regulations and industry patterns without particularized factual support. Contemporaneous notes, claim examples with dates and amounts, and records showing who ordered what and who knew it are the difference between a complaint that survives and one that ends at the pleading stage. For patients and families, the mirror lesson is evidentiary: the same specificity that courts demand of relators is what makes a beneficiary’s dispute or report effective. A report that says a named test on a named date was never ordered, with the calendar and portal records to show it, travels through the system. A report that says billing “feels wrong” does not.

The civil side also explains why providers correct documented disputes quickly. A single false claim can draw civil false-claims exposure, civil money penalties under the framework readers can consult in 42 U.S.C. 1320a-7a, and exclusion from federal health care programs, on top of any criminal risk for knowing conduct. None of those consequences falls on a beneficiary who merely received a confusing bill, and readers should not threaten them in a dispute letter. The point is quieter: billing offices triage by documentation quality, and a short written dispute with dates, service descriptions, amounts, and attached records signals that the file is complete and reviewable. Pair that letter with the calendar-against-statement comparison and the official reporting channel described above, keep copies of everything sent, and avoid paying a disputed balance simply to stop collection calls before the underlying discrepancy is resolved, since payment can complicate later correction of the claim record.

A final word on timing and on the CRUSH proposal: the RFI’s comment period closed March 30, 2026, and no final CRUSH rule is cited in any source read for this article, so readers should treat CRUSH as a statement of enforcement direction, not as a new billing obligation. The obligations that exist today come from the statutes and program rules already in force and from the case law applying them, including the three 2026 decisions above. When a final rule does arrive, its Federal Register publication, effective date, and applicability language will determine who must do what and by when. Until then, the reader’s best tools are the ones this article has sourced: check the statement against personal records, dispute specifics in writing, use the official reporting path for suspected fraud, and measure every alarming headline against the published enforcement record rather than the other way around.

Conclusion

The fraud crackdown behind this week’s searches is an enforcement surge with published numbers, not a change in what an ordinary medical bill must contain. The Justice Department’s record takedown, the billions CMS blocked, and the CRUSH request for information show where federal attention is concentrated: remote-ordered genetic testing, equipment that never arrived, telemedicine that never happened, and claims disconnected from documented care. The three 2026 appellate decisions confirm the pattern from the courtroom side. Joyner kept a 72-month sentence in place for orders signed for strangers, and Motley left a durable-equipment fraud established while vacating only the identity-theft count for resentencing. Enloe closed the courthouse door, for now, on a civil whistleblower whose allegations lacked the specific facts courts require. For readers, the lesson is practical rather than alarming: keep the calendar, compare it with every statement, dispute the specific line in writing, report suspected fraud through Medicare’s official channel, and never authorize tests or equipment by phone or signature for strangers. Bills that match documented care need no action. Bills that do not match deserve the documented, step-by-step treatment this article has described.

📄 Official circular